price close busi march
provid hcit recap preview
report updat estim provider-focus hcit compani follow
dec earn report updat guidanc manag discuss quarter
suppli evid provid market continu post-meaning
use challeng health system contempl go-forward strategi transit
albeit slowli value-bas care analyt patient engag consumer
virtual care top initi provid coverag list question
expans area acceler growth
expect
diversif new channel vendor allscript premier continu
highlight emerg growth opportun custom channel outsid core
provid segment specif payer employ life scienc drumbeat
continu get louder evidenc provid compound-annual-growth-rate
top pick remain non-provid group top-pick hiiq
non-provid segment recommend investor greater exposur
non-provid hcit group ytd vs provid hcit
non-provid vs provid hcit
allscript reiter buy lower estim post-netsmart
lower pt name continu valu play hcit
consider nois exist tough comp given netsmart longer consolid
focus payer life scienc segment acceler growth
howev revenu still small compon regardless compani
attract adj-ebitda assum core provid busi remain
rel stabl guidanc maintain share could work higher
reiter buy rais pt slightli
lower revenue ep declar dividend lifelin investor
follow disappoint guidanc conserv long-term growth
outlook provid himss believ management take conserv approach
guidanc given recent track record especi revenue stellar assum
guid conserv in-lin could view favor tout visibl
mid-point revenue guidanc larger dod va contract add visibl
maintain hold rais pt
rais revenue due providigm lower oper inc laerdal revenu headwind
begin exclud laerdal growth workforc provid solut
would get construct gain confid compani
verg growth acceler complet transform acquisit
renew file shelf registr acceler growth
premier reiter hold lower pt lower
estim post beat across board maintain
guidanc commentari mid-point adj-ebitda difficult comp due
headwind specialti pharmaci direct sourc combin
increment invest new product led guidanc rais present
busi lack catalyst get us construct
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object view
compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
buy lower pt
continu recommend share allscript stock offer investor valu
healthcar sector compani strategi last six year
opportunist front buy sell asset attempt grow market
share core provid clinic financi segment addit enter new
higher growth white space area allscript stori far clean
manag recogn stabil busi activ
tri gain market share drive improv growth rather stand still
recent compani monet acquisit netsmart
gener proce pre-tax gain netsmart
divest allscript judg core provid busi
emerg payer life scienc busi oper brand veradigm
compani gener solid manag target
rang adj-net incom impli follow
sale netsmart repay debt compani deliv
significantli adj-ebitda addit expect compani
activ share repurchas program buyback
remain current author
jp morgan health confer januari provid growth
outlook core provid busi veradigm
believ target appear achiev despit deliv
respect growth adj-ebitda adj-ep period
unfortun share deliv attract return
sharehold similarli publicli trade provider-focus compani
also fail deliv meaning share appreci last year
price target valuat netsmart transact complet lower
pt appli multipl project adj-ebtida
impli price target return nearli current level present
share trade roughli adj-ebitda contrast peer group
provider-focus hcit compani trade averag multipl believ
discount valuat dissip time compani show stabil
growth core unit financi result lap activ nois
chang metric provid guidanc past year
compani provid annual revenu adjust ebitda core netsmart
adjust ep year provid guidanc book adjust
ep pose sever challeng one revenu profit
challeng model
book guidanc impli declin
book exclud netsmart manag state
book guid in-lin compani long-term organ
revenu growth target
adjust ep guidanc impli declin
actual adjust ep
revenu guidanc impli flat revenu
growth howev includ partial quarter practic fusion
acquir full quarter onecont divest
net impact two transact impli organ
growth would
tax rate guidanc call effect tax rate
book post record book y/i quarter
far surpass cg consensu estim respect
record book attribut broad-bas strength even though netsmart
contribut solid book number core book exclud netsmart
revenu miss non-gaap revenu y/i came cg
consensu estim respect miss vs estim
due equal netsmart upgrad delay mdrx core busi
manag expect delay push
adjust ebitda miss adjust ebitda also came cg
consensu estim respect addit lower
expect revenu growth netsmart upgrad delay higher expect
health care cost contribut adjust ebitda miss
adjust ep miss adjust ep y/i in-lin cg estim
fell penni consensu
growth support growth growth non- growth support maint gross growth servic gross growth growth growth growth growth growth incom ep adjust growth growth support maint gross servic gross gross taxepsebitdaopexbookingsnon- revenue cgconsensusgross profit figur guidanc estim revis
figur price chart move averag
hold rais pt
although share react favor report guid maintain
neutral posit reiter hold rate primari concern
relat normal growth workforc solut
provid solut segment addit growth rate normal
exacerb headwind annual revenu gener
laerdal heartcod begin roll revenu gener
posit side encourag develop altern
product suit collabor american red cross partial
off-set revenu declin laerdal product sold offer
higher margin heartcod solut addit sign
agreement rqi partner allow custom continu use
heartcod product learn center even
scenario receiv fee high margin use platform
deliv heartcod offer despit posit develop difficult
gaug substanti effort respect offset impend
regard growth normal workforc solut segment would like
see growth reacceler double-digit level time difficult
envis growth might emerg provid solut segment
acquisit last year credenti space help partial off-set
loss revenu howev growth appear normal
double-digit level well
current level share appear rel cheap compar saa
platform-as-a-servic health care compani probabl limit
downsid current level think possibl stock could bounc
execut guidanc long-term see catalyst could
drive share meaning higher thu believ prudent maintain hold
rate see growth reacceler least learn potenti catalyst
could provid line sight toward higher growth
price target valuat rais pt pt base
target multipl adj-ebitda repres discount
peer group multi-industri software- platform-as-a-servic technolog
compani target multipl premium provider-focus
hcit vendor time discount valuat warrant versu multi-
industri peer group compani expect begin encount revenu growth
headwind would view acceler growth exclud laerdal
revenu justif discount target valuat dissip
workforc solut guidanc impli growth
includ contribut providigm contribut laerdal
exclud providigm laerdal estim impli guidanc core
workforc solut notabl initi guidanc workforc
solut revenu growth provid maintain
throughout finish slightli mid-point without
strength laerdal believ probabl would finish
slightli low-end rang initi guidanc guidanc workforc
solut revenu provid lower
mid-way finish rang growth look
gain insight growth trajectori workforc core go forward
would catalyst reacceler growth come year
forecast workforc solut revenu grow
exclud laerdal forecast segment grow also
exclud acquir providigm busi forecast segment grow
providigm contribut recent acquir providigm jan
expect contribut revenu due amort expens
defer revenu write-down expect neg impact
oper incom impact defer revenu write-down
compon expect acquisit price cash
previous announc impli purchas multipl sale
laerdal revenu strong expect grow modestli
gener revenu laerdal heartcod product
anticip total revenu modestli higher revenu
peak near middl year forecast heartcod
revenu revenu peak mid-year wind
provid solut guidanc impli growth
compar initi guidanc provid compani
finish toward low-end rang follow report
demand character high implement constrain
question growth rate provid solut deceler
expect concern especi given spent three
acquisit healthlin morrisey sy med sinc enter provid
credenti privileg market hope combin asset
updat technolog platform achiev cross-sel success hstm
exist custom base compani would abl acceler revenu growth
base guidanc unfortun doesnt seem case
oper incom guidanc impli declin
margin initi guidanc oper incom impli
margin rais throughout year margin
compani finish rang margin would
anticip compani oper incom guidanc conserv
provid upsid estim throughout howev certain item
keep mind includ amort intang defer revenu write-down
providigm acquisit increment new hq facil expens
host cost referenc exit
new hq expens re-loc new hq nashvil tn result
increment oper expens annual
report posit result revenu beat consensu miss
cg oper incom beat estim impli guidanc
revenu beat vs consensu total revenu y/i beat consensu
miss cg workforc solut revenu y/i
in-lin cg beat consensu believ
street like factor enough growth relat laerdal thu revenu
workforc solut outperform vs consensu provid solut revenu
y/i miss cg consensu
oper incom beat oper incom y/i beat cg
consensu impli oper margin
oper beat enabl oper expens come forecast
product develop sale market off-set gross margin
forecast vs forecast
subscrib last time report new implement subscrib
q/q new contract subscrib q/q
sequenti declin new implement subscrib attribut larger health
system take non-employ physician volunt platform
meaning metric number contract subscrib
increas sequenti
addit compani provid hstream subscrib metric second
quarter subscrib end vs end
figur guidanc estim revis
growth growth growth growth growth growth growth growth growth growth growth growth growth expensesgross profitcgrevenueprior newmid-pointprior newprior newtot figur price chart move averag
buy rais pt
maintain buy rate time industri leader
liquid hcit stock continu core hold howev
believ compani need execut better versu guidanc otherwis
sharehold like step away
share held rel steadi despit mix result
guidanc updat long-term growth outlook provid earli februari
annual investor meet took conserv revenu growth stanc
compar last year outlook base side convers ceo
cfo investor meet clear compani aim under-
promis over-deliv order get past track record report mix
result versu guidanc estim case beat scenario play
share could set move higher progress given
stock stabl perceiv mix result guidanc long-term growth
outlook appear downsid may limit thu upward bia
price target valuat rais pt price target
roll averag multipl two-year forward estim
note could appear aggress given ep growth normal
recent annual growth risk multipl contract exist
compani doesnt execut investor doubt compani abil acceler
revenu earn growth addit dividend quarterli
begin provid impli yield clear introduct
dividend help support stock follow result
book track record beat book guidanc estim solid
may difficult beat consensu mid-point guidanc
expect book impli declin
rang notabl book prior year period includ high
level long-term book expect much lower
level long-term book assum includ long-term
book in-lin low-end long-term book last two
year would impli short-term book growth manag
indic exclud long-term book book
growth tradit size contract like grow year-ov year
note sever long-term deal expect sign
year pipelin consid strong despit experienc slight paus
larger deal
book track record consensu mid-point thu
make beat challeng estim mid-point
last quarter top mid-point guidanc time
report beat consensu quarterli report quarter
report compani beat top-end guidanc quarter fell
low-end rang
revenu poor track record meet guidanc mid-point howev believ
manag take conserv stanc in-lin
revenu guidanc y/i impli growth
mid-point impli mid-point would acceler
y/i growth post compani experienc soft
softwar purchas va contract remain unsign neg impact
revenu track record consensu slightli
mid-point guidanc make beat challeng updat estim
mid-point
last quarter top mid-point revenu guidanc
time report also beat consensu quarterli
report quarter report compani mid-point
quarter miss consensu revenu forecast
adj-ep consensu high-end guidanc rang believ
miss versu possibl
adj-ep guidanc impli growth y/i mid-
point current consensu sit top-end guidanc come
time report earli februari
back march
adj-ep track record consensu top-end rang
estim mid-point believ consensu achiev
howev would surpris mid-point print would in-
line estim penni consensu
last quarter top mid-point adj-ep guidanc time
report eat consensu quarterli report
quarter report compani in-lin mid-point quarter
mid-point guidanc versu consensu compani came in-lin
time miss time
revenu guidanc y/i impli mid-point
acceler prior issuanc guidanc consensu
subsequ move also worth
note consensu revenu estim march
higher current mid-point higher current consensu
discuss revenu guidanc compani detail visibl mid-point
revenu guidanc backlog expect convert revenu
contract includ backlog due revenu standard
associ contract termin claus manag also highlight
expect grow subscript revenu double-digit note solid subscript
book transact activ compani commentari detail
expect growth mani revenu front deceler revenu growth
pictur mention expect softwar growth rebound tech
resal servic growth outsid work busi
final manag invest commun meet himss compani
made clear take conserv stanc respect provid
guidanc long-term target would like return build track record
under-promis overachiev sens especi true revenu
target challeng achiev recent year
intrigu see fact guidanc conserv compani abl
execut guidanc
adj-ep guidanc rang mid-point
impli growth like achiev previous highlight thought
consensu exit report high novemb lower
estim compani provid formal
guidanc consensu move mid-point guidanc
decid lower ep estim thu take
conserv stanc interestingli look consensu back march
street forecast adj-ep illustr estim
notabl reign last year
oper cash flow expect show limit growth manag expect
ocf show limit growth due benefit
tax refund addit expect expens voluntari separ
free cash flow expect declin manag expect declin
due limit ocf growth note coupl increas capital-expenditure
expect increas
highlight investor day himss
long-term revenu growth target lower compani lower long-term revenu
growth target compound-annual-growth-rate target provid
last year analyst day compound-annual-growth-rate notabl new target
older higher target
revenu miss expect despit consensu estim
mid-point guidanc still expect revenu miss base
compani past track record recent quarter miss revenu guidanc revenu
y/i fell short cg consensu estim
respect revenu miss larg due technolog resal revenu
declin y/i
adj-ep in-lin also expect adj-ep y/i
penni estim in-lin consensu mid-point
guidanc state preview note expect in-
line quarter adj-ep base compani track record deliv in-lin
result in-lin adj-ep possibl despit revenu miss
revenu miss due lower expect tech resal rel low
book rel in-lin book y/i fell
short cg estimate beat consensu slightli ahead mid-
point guidanc upsid foreshadow
possibl preview note typic fourth quarter book season
stronger compani close fiscal year
figur guidanc estim revis
 growth growth support mainten growth growth growth growth client growth growth growth acquisition-rel growth growth interest expens adjust growth growth sale gross mainten servic gross gross client acquisition-rel oper taxbook-ingsepsmarginsrevenueoper expensesebitdagpmcgconsensusebitprior newmid-pointprior newprior figur guidanc estim revis
figur price chart move averag
hold lower pt
maintain hold rate present near-term headwind exist
catalyst although note address guidanc
affirm despit top revenu adj-ebitda estim would also point
compani state anticip mid-point adj-ebitda
specif headwind note includ reimburs compress dir
fee specialti pharmaci busi product relat cost direct sourc
partial off-set growth gpo net administr fee also like
continu nois relat adopt fact
coverag list seem one compani impact
upsid estim may challeng given headwind includ
competit price pressur gpm product busi specialti pharmaci
reimburs adopt make comparison
challeng still call increment plan invest
integr stanson develop new high-valu network employer/pay
offer providegx address gener drug suppli shortag
estim appear incorpor manag commentari revenu
slightli mid-point howev adj-ebitda slightli mid-point
may still aggress consid manag commentari consensu adj-
ebitda estim come report
follow report compar mid-point
consid appear lack catalyst stock
rich valuat perspect decid maintain neutral stanc
reiter hold rate
price target valuat lower pt base
target multipl adj-ebitda y/i target
multipl discount provider-focus peer group trade
adj-ebitda share current trade adj-ebitda estim
given expect post y/i adj-ebitda declin contend
discount target multipl warrant would look re-evaluate target
multipl becom comfort headwind specialti
pharmaci direct sourc diminish optic tough comp follow
transit move rearview mirror
posit highlight watch beyond
posit report repres growth opportun
beyond new custom front detail final stage
sign advoc -aurora largest non-profit health system
enterprise-wid suppli chain perform improv servic includ gpo
servic addit client particip premier bundl payment
new product servic front sever area highlight
compani make effort address gener drug shortag expand custom
channel includ life scienc compani develop employ payer
market potenti custom channel note effort help health
system minim impact gener drug shortag enabl uninterrupt access
product experienc shortag compani new subsidiari providegx
activ work manufactur creat consist access supply-constrain
drug target steril inject drug premier also tout appli
scienc effort leverag compani data health system provid
client pharma analyz evalu effect variou product
ultim improv qualiti effect anoth new potenti growth channel
develop high-valu network target nation employ given
broad nation client base hospit health system look leverag
creat provid network potenti contract employ
deliv high qualiti cost-effect care employe initi stage
eager hear progress go forward
guidanc maintain two new updat
stock-bas compens expect
adjust ebitda adjust ep expect mid-point
guidanc rang due reimburs compress competit price
pressur gross margin product busi addit
respect quarterli cadenc remaind year manag
provid follow commentari
net admin fee expect grow low-to-mid-singl digit
net admin fee expect lower due higher net admin
fee relat acceler cash collect lead convers
start
manag continu anticip low-to-mid singl digit growth
net admin fee
revenu expect grow low-singl digit
manag continu anticip revenu growth
revenu expect equal weight
vs previou expect due
two factor result acceler revenu recognit
licens revenu pull onto balanc sheet
due
still expect high-wat mark term revenu
sequenti declin
report in-lin estim convert
forecast follow report provid
result compar estim addit
result compar year ago period
revenu beat bolster perform servic total revenu
beat cg consensu respect suppli chain servic
revenu came slightli estim miss cg consensu
respect offset slight suppli chain miss
perform servic revenu nice beat cg consensu estim
respect
term order compar year ago period
provid term total revenu suppli chain servic perform
servic revenu grew respect
adjust ebitda beat also bolster perform servic total adj-ebitda
impli margin beat cg consensu estim
respect suppli chain servic adj-ebitda
came cg consensu estim respect
perform servic adj-ebitda outperform enabl overal beat
beat cg consensu estim respect
figur guidanc estim revis
chain servic growth servic growth growth growth gener amort purchas oper growth net inc unconsolid incom tax tax fulli distrbut growth chain servic adjust growth servic adjust growth growth term newmid-pointprior newprior newsuppli chain figur price chart move averag
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
incom eyear eyear esoftwar deliveri support mainten client servic total non- growth deliveri support mainten client servic total growth sequenti -- -- growth revenuesoftwar deliveri support client amort capit softwar develop amort acquisition-rel intang total cost gross asset impair goodwil impair charge- total growth interest incom equiti net earn unconsolid pre-tax tax net incom continu net incom discontinu op net net incom non-control accret redempt convert netsmart- net incom dilut ep growth growth net incom non- net incom non-control non- net incom growth growth deliveri growth servic growth growth analysi softwar deliveri support client deliveri support mainten gross servic gross gross effect tax figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
incom statement eyear eyear eworkforc growth growth growth growth growth annual ex gross oper expensesproduct sale depreci gener extraordinari non-recur items/sfa total oper oper growth incomeinterest interest expense- total earn provis incom tax net incom continu basic ep continu dilut ep continu non- ebitda continu growth oper growth net non- dilut growth share dilut share margin analysi gross expensesproduct gener oper oper ebitda incom expens incom figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
incom statement fiscal eyear eyear esystem support mainten servicessupport total support mainten total growth sequenti -- -- growth gross sale client softwar gener write-off process d- amort acquisition-rel oper oper adjust oper growth interest expens pre-tax tax net dilut dilut growth growth net incomestock settlement charg net tax- one time item net acquisition-rel tax benefit estimate adjust net adjust growth growth analysistot gross client acquisition-rel oper incom figur incom statement
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may obtain contact canaccord genuiti sale person author analyst whose contact
inform appear front page report
incom june eyear eyear growth growth revenu suppli chain growth administr servic total revenu servic total cost servic gross product gross total gross growth oper income- sell gener research amort purchas intang pro-forma adjustment- total oper oper growth incom expens equiti net incom unconsolid interest invest incom incom dispos assets/ total incom incom tax net net loss non-controlling interest net incom non-controlling interest premier adj redeem lp capit redempt net incom loss share ep ep ebitda adjust growth fulli distribut net fulli distribut share adjust fulli distribut growth chain servic adjust servic adjust analysisservic gross gross gross gener purchas intang fulli distribut chain servic adjust servic adjust ebitda healthcar
